First Foundation Advisors’s Allergan plc AGN.PRA Stock Holding History

First Foundation Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,006	Closed	-$4.11M	–	361
2017 Q4	$4.11M	Sell	7,006 -724	-9%	-$467K	0.22%	72
2017 Q3	$5.7M	Buy	7,730 +1,467	+23%	+$1.22M	0.32%	55
2017 Q2	$5.43M	Buy	6,263 +113	+2%	+$94.7K	0.32%	54
2017 Q1	$5.22M	Sell	6,150 -1,253	-17%	-$1.04M	0.32%	55
2016 Q4	$5.64M	Buy	7,403 +1,347	+22%	+$1.02M	0.37%	57
2016 Q3	$4.97M	Buy	6,056 +2,418	+66%	+$2.09M	0.34%	58
2016 Q2	$3.03M	Buy	+3,638	New	+$3.04M	0.22%	76

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

First Foundation Advisors's AGN.PRA Position: Q1 2018 in Review

First Foundation Advisors sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 7,006 shares — an estimated $4.11M sold.

First Foundation Advisors first reported a position in AGN.PRA in Q2 2016 and held it in 7 quarters. The position peaked at $5.7M in Q3 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

First Foundation Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
First Foundation Advisors sold 7,006 Allergan plc shares in Q1 2018, an estimated $4.11M.
First Foundation Advisors first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
First Foundation Advisors's Allergan plc position peaked at $5.7M in Q3 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on First Foundation Advisors's 13F filing for Q1 2018, filed 15 May 2018.